hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06318104, orgStudyIdInfo id: DI/24/310/03/4, briefTitle: Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-04-19, primaryCompletionDateStruct date: 2024-11-29, completionDateStruct date: 2025-02-28, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Hospital General de México Dr. Eduardo Liceaga, class: OTHER_GOV, descriptionModule briefSummary: In Mexico, quadruple therapy is used to treat Helicobacter pylori (H.P.) at the expense of greater adverse effects, costs, and lower adherence to treatment. According to evidence, a competitive potassium channel blocker (P-CAB) is non-inferior to a proton pump inhibitor (PPI) and can improve the eradication rate of H.P. while maintaining triple therapy antibiotics (amoxicillin-clarithromycin) without increasing adverse effects, fewer drugs and better adherence to treatment. It is proposed to study the effect of a P-CAB in the eradication of H.P. as part of a triple therapy in Mexican patients, assuming that the efficacy and safety of a triple therapy of amoxicillin-clarithromycin-tegoprazan will be superior to amoxicillin-clarithromycin-esomeprazole., conditionsModule conditions: Helicobacter Pylori Infection, designModule studyType: INTERVENTIONAL, phases: PHASE4, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 160, type: ESTIMATED, armsInterventionsModule interventions name: Tegoprazan, interventions name: Esomeprazole 40mg, outcomesModule primaryOutcomes measure: Response to treatment by determining the eradication rate, primaryOutcomes measure: Compared Treatment-related adverse events, secondaryOutcomes measure: Brief Medication Questionnaire, secondaryOutcomes measure: Percentage of patients with adherence to treatment, secondaryOutcomes measure: Report all Treatment-related adverse events, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06318091, orgStudyIdInfo id: MS.21.09.1640, briefTitle: Nanofat Versus Platelet Poor Plasma Gel for Infraorbital Rejuvenation, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-06-01, primaryCompletionDateStruct date: 2023-06-01, completionDateStruct date: 2023-06-01, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Mansoura University, class: OTHER, descriptionModule briefSummary: this study was conducted for evaluation of the clinical efficacy, safety, and potential side effects of platelet poor plasma gel versus nonfat injection in infraorbital rejuvenation, conditionsModule conditions: Tear Trough Eyelid Deformity, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: platelet poor plasma gel, interventions name: nanofat, outcomesModule primaryOutcomes measure: the degree of changes in the skin texture and homogeneity, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Manousra University, Faculty of Medicine, city: Mansoura, state: Dakahlia, zip: 35511, country: Egypt, geoPoint lat: 31.03637, lon: 31.38069, hasResults: False
protocolSection identificationModule nctId: NCT06318078, orgStudyIdInfo id: UG2024001, briefTitle: Buikwe Electronic Community Health Information System Impact Study, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-12-01, primaryCompletionDateStruct date: 2024-04, completionDateStruct date: 2024-07, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Malaria Consortium, class: OTHER, descriptionModule briefSummary: The purpose of the study is to investigate the impact of the eCHIS intervention on key child health outcomes., conditionsModule conditions: Malaria, conditions: Diarrhea, conditions: Pneumonia, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Cluster Randomised Control Trial, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: NONE, enrollmentInfo count: 1140, type: ESTIMATED, armsInterventionsModule interventions name: eCHIS, outcomesModule primaryOutcomes measure: Out Patient Department attendance (due to malaria, pneumonia and diarrhoea), primaryOutcomes measure: Hospitalisation (due to malaria, pneumonia and diarrhoea), primaryOutcomes measure: malaria related mortality in the community and health facilities, eligibilityModule sex: ALL, minimumAge: 3 Months, maximumAge: 59 Months, stdAges: CHILD, contactsLocationsModule locations facility: Buikwe, status: RECRUITING, city: Buikwe, country: Uganda, contacts name: John Baptist Bwanika, MD, role: CONTACT, contacts name: John Baptist Bwanika, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 0.3375, lon: 33.01056, hasResults: False
protocolSection identificationModule nctId: NCT06318065, orgStudyIdInfo id: B-ER111-370, briefTitle: Surgical Resection Outcomes in Patients With Brain Metastasis, statusModule overallStatus: RECRUITING, startDateStruct date: 2010-01-01, primaryCompletionDateStruct date: 2024-06-01, completionDateStruct date: 2024-09-01, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-22, sponsorCollaboratorsModule leadSponsor name: National Cheng-Kung University Hospital, class: OTHER, descriptionModule briefSummary: While many studies have investigated the prognostic factors for patients undergoing surgical resection for primary brain tumors, decision-making for patients with brain metastasis (BM) is more complex because of their higher burden of comorbidities compared to those with primary brain tumors. In addition, although various prognostic indicators have been identified to predict prognosis in several types of cancer, such as the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), prognostic nutritional index (PNI), and systemic immune-inflammation index (SII), limited studies have yet determined which group of patients would yield beater survival outcome after surgical resection for BM. This study aimed to investigate the impact of patient and perioperative characteristics and prognostic indicators on survival outcome of patients undergoing surgical resection of BM., conditionsModule conditions: Brain Metastases, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: RETROSPECTIVE, enrollmentInfo count: 100, type: ESTIMATED, outcomesModule primaryOutcomes measure: survival outcome of patients undergoing surgery for brain metastasis, primaryOutcomes measure: Functional outcome of patients undergoing surgery for brain metastasis, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Jung-Shun Lee, status: RECRUITING, city: Tainan, state: None Selected, zip: 70403, country: Taiwan, contacts name: Jung-Shun Lee, M.D., role: CONTACT, phone: 886-6-2353535, phoneExt: 5181, email: nslee1218@gmail.com, geoPoint lat: 22.99083, lon: 120.21333, hasResults: False
protocolSection identificationModule nctId: NCT06318052, orgStudyIdInfo id: LUM-ABU-CO2-FemTouch-19-01, briefTitle: The Effect Of Fractional CO2 Laser Therapy On Cancer Survivors With Genitourinary Syndrome Of Menopause (GSM), statusModule overallStatus: RECRUITING, startDateStruct date: 2019-11-01, primaryCompletionDateStruct date: 2024-11, completionDateStruct date: 2024-11, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: Lumenis Be Ltd., class: INDUSTRY, descriptionModule briefSummary: Improvement in cancer therapies has led to an increase in the number of women surviving chemotherapy (and other treatments) and overcoming cancer. This patient population presents specific clinical needs as chemotherapy (and other cancer treatments) treatment side effects can lead to early appearance of menopause symptoms and conventional hormonal treatments are contraindicated for these patients. The use of CO2 laser treatment has been shown to provide relief of Genitourinary Syndrome Of Menopause (GSM) symptoms in women and might provide a significant improvement in the quality of life for cancer survivors. The current study is designed to demonstrate the safety and efficacy of CO2 laser for treatment of GSM symptoms in cancer survivors suffering from GSM symptoms, with limited access to hormonal treatment., conditionsModule conditions: Vaginal Atrophy Patients With GSM, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 68, type: ESTIMATED, armsInterventionsModule interventions name: The FemTouch delivery system, interventions name: Gynomunal gel treatment, outcomesModule primaryOutcomes measure: To demonstrate the efficacy of fractionated CO2 laser treatments in cancer survivor patients with GSM as compared to the standard treatment, secondaryOutcomes measure: To demonstrate the efficacy of fractionated CO2 laser treatments in cancer survivor patients with GSM as compared to the standard treatment, secondaryOutcomes measure: To demonstrate the efficacy of fractionated CO2 laser treatments in cancer survivor patients with GSM as compared to the standard treatment., eligibilityModule sex: FEMALE, minimumAge: 21 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Frauenarztpraxis Heussweg, status: RECRUITING, city: Hamburg, zip: 20255, country: Germany, contacts name: Matthias Theden-Scow, Dr, role: CONTACT, phone: 4210613, phoneExt: 040, email: dr.theden-schow@hamburg.de, geoPoint lat: 53.57532, lon: 10.01534, hasResults: False
protocolSection identificationModule nctId: NCT06318039, orgStudyIdInfo id: IRB2022-06554-01, briefTitle: Operation ACL: Rehabilitation After Anterior Cruciate Ligament Reconstruction, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-10-01, primaryCompletionDateStruct date: 2027-03-01, completionDateStruct date: 2027-10-01, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-04-08, sponsorCollaboratorsModule leadSponsor name: Linnaeus University, class: OTHER, descriptionModule briefSummary: Scientific Research QuestionOverall Purpose:Regarding rehabilitation after anterior cruciate ligament reconstruction (ACLR), there is a knowledge gap - a lack of evidence. Important questions such as how rehabilitation should be structured, what it should include, and how it should be evaluated are currently not clear. Therefore, the investigators plan to conduct a two-year follow-up randomized controlled trial (RCT) on post-ACLR rehabilitation.Moreover, detailed information on how/under what circumstances the ACL injury occurred is not satisfactorily described in the literature. Therefore, the investigators are planning a new survey that can identify, explain, and prevent the risk factors causing a person to suffer from an anterior cruciate ligament injury.Specific Objectives:How should guidelines for rehabilitation after ACLR be structured, what should they include, and how should they be evaluated to best restore knee function in the patient? Can a detailed and comprehensive survey identify, explain, and prevent the risk factors causing a person to suffer from an ACL injury?, conditionsModule conditions: Anterior Cruciate Ligament Reconstruction, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: randomized controlled trial, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 100, type: ESTIMATED, armsInterventionsModule interventions name: Novel program, interventions name: Traditional program, outcomesModule primaryOutcomes measure: Isokinetic muscle strength, primaryOutcomes measure: Single-leg hop performance, secondaryOutcomes measure: Knee Injury and Osteoarthritis Outcome Score (KOOS), secondaryOutcomes measure: ACL Return to Sport after Injury scale, eligibilityModule sex: ALL, stdAges: CHILD, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Linnaeus University, city: Kalmar, state: Sverige, zip: 39363, country: Sweden, geoPoint lat: 56.66157, lon: 16.36163, hasResults: False
protocolSection identificationModule nctId: NCT06318026, orgStudyIdInfo id: R01AA031231, type: NIH, link: https://reporter.nih.gov/quickSearch/R01AA031231, secondaryIdInfos id: R01AA031231, type: NIH, link: https://reporter.nih.gov/quickSearch/R01AA031231, briefTitle: Systematic Implementation of Patient-centered Care for Alcohol Use Trial: Beyond Referral to Treatment, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-07, primaryCompletionDateStruct date: 2029-02, completionDateStruct date: 2029-02, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: Kaiser Permanente, class: OTHER, collaborators name: National Institute on Alcohol Abuse and Alcoholism (NIAAA), collaborators name: Kaiser Permanente Washington, collaborators name: University of Washington, descriptionModule briefSummary: The Systematic Implementation of Patient-centered Care for Alcohol Use Trial is a pragmatic, cluster-randomized, effectiveness-implementation trial testing two interventions to systematically implement shared decision-making with primary care patients with symptoms due to alcohol use: a primary care intervention and a centralized intervention. An anticipated 30 primary care clinics will be randomized to one of three conditions: usual care or the primary care or centralized interventions., conditionsModule conditions: Alcohol Use Disorder, conditions: Unhealthy Alcohol Use, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: HEALTH_SERVICES_RESEARCH, maskingInfo masking: SINGLE, maskingDescription: EHR and survey (latter masked), whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 1500, type: ESTIMATED, armsInterventionsModule interventions name: Centralized Intervention, interventions name: Primary Care Intervention, outcomesModule primaryOutcomes measure: Documentation of alcohol or substance use disorder treatment in the electronic health record (including insurance claims)., primaryOutcomes measure: Continuous measure of change in alcohol use as documented on the AUDIT-C screening questionnaire., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Kaiser Permanente Washington, city: Seattle, state: Washington, zip: 98112, country: United States, contacts name: Megan Addis, role: CONTACT, phone: 206-287-2052, email: Megan.J.Addis@kp.org, geoPoint lat: 47.60621, lon: -122.33207, hasResults: False
protocolSection identificationModule nctId: NCT06318013, orgStudyIdInfo id: 2022-KAEK-15427-04-204-2022101, briefTitle: Perineural and Systemic Dexamethasone Use in Dental Surgeries in Terms of Anesthesia Duration and Postop Complaints, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-27, primaryCompletionDateStruct date: 2024-04-15, completionDateStruct date: 2024-07-01, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-29, sponsorCollaboratorsModule leadSponsor name: Karamanoğlu Mehmetbey University, class: OTHER, descriptionModule briefSummary: Participants will be asked to use some medications after the tooth extraction procedure. These drugs can be used in different ways. Investigators plan to monitor the pain, swelling and duration of anesthesia in the body as a result of participants use., conditionsModule conditions: Impacted Third Molar Tooth, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_CONTROL, timePerspective: OTHER, enrollmentInfo count: 60, type: ESTIMATED, armsInterventionsModule interventions name: vitality test, outcomesModule primaryOutcomes measure: Swelling, primaryOutcomes measure: Duration of anesthesia, secondaryOutcomes measure: Pain Score, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 35 Years, stdAges: ADULT, contactsLocationsModule locations facility: Karamanoğlu Mehmetbey University Ahmet Keleşoğlu Faculty of Dentistry, status: RECRUITING, city: Karaman, zip: 70100, country: Turkey, contacts name: Faruk Ayhan Başçiftçi, Dr, role: CONTACT, phone: 338-226-2082, email: dis@kmu.edu.tr, contacts name: Sümeyye Çelik Özsoy, Dr, role: CONTACT, phone: 338-226-2082, email: sumeyyecelik@kmu.edu.tr, contacts name: Doğan Ilgaz Kaya, Dr, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 37.18111, lon: 33.215, hasResults: False
protocolSection identificationModule nctId: NCT06318000, orgStudyIdInfo id: SN4/20/22, briefTitle: Physical Activity and Sports for People With Visual Impairments, statusModule overallStatus: COMPLETED, startDateStruct date: 2020-03-01, primaryCompletionDateStruct date: 2022-12-31, completionDateStruct date: 2022-12-31, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-20, sponsorCollaboratorsModule leadSponsor name: Józef Piłsudski University of Physical Education, class: OTHER, descriptionModule briefSummary: Purpose of this study was to assess the relationship between the visual impairment degree and the level of children's fundamental motor skills, balance and bilateral coordination., conditionsModule conditions: Blindness, conditions: Visual Impairment, designModule studyType: OBSERVATIONAL, designInfo observationalModel: CASE_ONLY, timePerspective: CROSS_SECTIONAL, enrollmentInfo count: 76, type: ACTUAL, armsInterventionsModule interventions name: Balance test, bilateral coordination test, fundamental motor skills test, outcomesModule primaryOutcomes measure: Center of pressure (CoP) path length was measured, primaryOutcomes measure: Surface area of stabilogram was measured, primaryOutcomes measure: Raw and scale score for each item, primaryOutcomes measure: Qualitative performance criteria (points), secondaryOutcomes measure: Body mass in kg, secondaryOutcomes measure: Body height in cm, eligibilityModule sex: ALL, minimumAge: 7 Years, maximumAge: 17 Years, stdAges: CHILD, contactsLocationsModule locations facility: University of Physical Education, city: Warsaw, zip: 00-968, country: Poland, geoPoint lat: 52.22977, lon: 21.01178, hasResults: False
protocolSection identificationModule nctId: NCT06317974, orgStudyIdInfo id: 2022/210, briefTitle: The Effect of Breastfeeding Education on Breast Milk Perception and Self-Efficacy in the Pregnancy Health Belief Model, statusModule overallStatus: COMPLETED, startDateStruct date: 2022-06-30, primaryCompletionDateStruct date: 2022-12-31, completionDateStruct date: 2023-02-15, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Istanbul University - Cerrahpasa (IUC), class: OTHER, descriptionModule briefSummary: Objective: The aim of this study was to evaluate the effect of breastfeeding education based on the Health Belief Model during the antenatal period on couples' perception and self-efficacy regarding breast milk., conditionsModule conditions: Breastfeeding Education, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Randomized controlled, experimental research design in pre-test, post-test design Made with, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: DOUBLE, whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 220, type: ACTUAL, armsInterventionsModule interventions name: Breastfeeding education based on the Health Belief model, outcomesModule primaryOutcomes measure: Mothers' and fathers' perception of breast milk, assessed using the Adults' Breast Milk Perception Scale., secondaryOutcomes measure: Breastfeeding self-efficacy of mothers evaluated using the Breastfeeding Self-Efficacy Scale-Short Form during Pregnancy, otherOutcomes measure: Paternal breastfeeding self-efficacy assessed using the Paternal Breastfeeding Self-Efficacy Scale., eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Istanbul University - Cerrahpasa, city: Istanbul, country: Turkey, geoPoint lat: 41.01384, lon: 28.94966, hasResults: False
protocolSection identificationModule nctId: NCT06317961, orgStudyIdInfo id: INT200-22, briefTitle: Pilot Study on the Use of iENTER, iCONSENT and iPARTICIPATE E-tools, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-04-05, primaryCompletionDateStruct date: 2025-01-31, completionDateStruct date: 2025-01-31, studyFirstPostDateStruct date: 2024-03-19, lastUpdatePostDateStruct date: 2024-03-19, sponsorCollaboratorsModule leadSponsor name: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, class: OTHER, collaborators name: Vall d'Hebron Institute of Oncology, collaborators name: The Netherlands Cancer Institute, descriptionModule briefSummary: Precision oncology is the future of fighting cancer. Cancer Core Europe (CCE) developed a precision medicine trial, i.e. the Basket of Basket (BoB) study, to provide personalised treatment to a large number of patients by incorporating a molecular profiling platform. The EU-funded CCE_DART project, developed within the CCE Consortium, is aimed at improving efficiency and transform platform trials into data-rich translational research programmes. Within the CCE_DART project working area D "Patient involvement through information and partnership" three interconnected web e-tools were developed aimed at promoting patient information, recruitment, and involvement as well as facilitating adherence to the CCE BoB trial: 1) iENTER: informative web site addressed to potential BoB trial participants, their caregivers, patients' advocates, and the public; 2) iCONSENT: web app for remote management of the informed consent process in the CCE BoB trial.3) iPARTICIPATE: web app allowing remote access to BoB trial patients trial visits calendar, medications list and posology, to upload documents and download reports, messaging between patients and clinical staff. The main objective of this study is to carry out field testing and assess usability of the e-tools iENTER, iCONSENT and iPARTICIPATE. The study is also addressed at collecting patients' suggestions for improvements of the e-tools., conditionsModule conditions: Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 30, type: ESTIMATED, outcomesModule primaryOutcomes measure: SUS questionnaire, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fondazione IRCCS Istituto Nazionale dei Tumori, status: RECRUITING, city: Milano, zip: 20133, country: Italy, contacts name: Rosalba Miceli, PhD, role: CONTACT, phone: +39 0223903198, email: rosalba.miceli@istitutotumori.mi.it, contacts name: Sara Iadecola, role: CONTACT, phone: +39 0223903198, email: sara.iadecola@istitutotumori.mi.it, geoPoint lat: 45.46427, lon: 9.18951, hasResults: False